TY - JOUR
T1 - Biological subphenotypes of acute respiratory distress syndrome may not reflect differences in alveolar inflammation
AU - Heijnen, N.F.L.
AU - Hagens, L.A.
AU - Smit, M.R.
AU - Schultz, M.J.
AU - van der Poll, T.
AU - Schnabel, R.M.
AU - van der Horst, I.C.C.
AU - Dickson, R.P.
AU - Bergmans, D.C.J.J.
AU - Bos, L.D.J.
AU - BASIC Consortium
N1 - Funding Information:
The Center of Translational Medicine supported the sample and clinical data collection via the MARS consortium. Additional support came from the Longfonds (Dutch Lung Foundation) via the private-partnership program. The authors were supported by the National Institutes for Health (K23HL130641 (RPD), R21AI137669 (RPD), R01HL144599 (RPD). Additional support was provided by the University of Michigan Center for Integrative Research in Critical Care (RPD).
Funding Information:
The Center of Translational Medicine supported the sample and clinical data collection via the MARS consortium. Additional support came from the Longfonds (Dutch Lung Foundation) via the private‐partnership program. The authors were supported by the National Institutes for Health (K23HL130641 (RPD), R21AI137669 (RPD), R01HL144599 (RPD). Additional support was provided by the University of Michigan Center for Integrative Research in Critical Care (RPD).
Publisher Copyright:
© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Biological subphenotypes have been identified in acute respiratory distress syndrome (ARDS) based on two parsimonious models: the "uninflamed" and "reactive" subphenotype (cluster-model) and "hypo-inflammatory" and "hyper-inflammatory" (latent class analysis (LCA) model). The distinction between the subphenotypes is mainly driven by inflammatory and coagulation markers in plasma. However, systemic inflammation is not specific for ARDS and it is unknown whether these subphenotypes also reflect differences in the alveolar compartment. Alveolar inflammation and dysbiosis of the lung microbiome have shown to be important mediators in the development of lung injury. This study aimed to determine whether the "reactive" or "hyper-inflammatory" biological subphenotype also had higher concentrations of inflammatory mediators and enrichment of gut-associated bacteria in the lung. Levels of alveolar inflammatory mediators myeloperoxidase (MPO), surfactant protein D (SPD), interleukin (IL)-1b, IL-6, IL-10, IL-8, interferon gamma (IFN), and tumor necrosis factor-alpha (TNF alpha) were determined in the mini-BAL fluid. Key features of the lung microbiome were measured: bacterial burden (16S rRNA gene copies/ml), community diversity (Shannon Diversity Index), and community composition. No statistically significant differences between the "uninflamed" and "reactive" ARDS subphenotypes were found in a selected set of alveolar inflammatory mediators and key features of the lung microbiome. LCA-derived subphenotypes and stratification based on cause of ARDS (direct vs. indirect) showed similar profiles, suggesting that current subphenotypes may not reflect the alveolar host response. It is important for future research to elucidate the pulmonary biology within each subphenotype properly, which is arguably a target for intervention.
AB - Biological subphenotypes have been identified in acute respiratory distress syndrome (ARDS) based on two parsimonious models: the "uninflamed" and "reactive" subphenotype (cluster-model) and "hypo-inflammatory" and "hyper-inflammatory" (latent class analysis (LCA) model). The distinction between the subphenotypes is mainly driven by inflammatory and coagulation markers in plasma. However, systemic inflammation is not specific for ARDS and it is unknown whether these subphenotypes also reflect differences in the alveolar compartment. Alveolar inflammation and dysbiosis of the lung microbiome have shown to be important mediators in the development of lung injury. This study aimed to determine whether the "reactive" or "hyper-inflammatory" biological subphenotype also had higher concentrations of inflammatory mediators and enrichment of gut-associated bacteria in the lung. Levels of alveolar inflammatory mediators myeloperoxidase (MPO), surfactant protein D (SPD), interleukin (IL)-1b, IL-6, IL-10, IL-8, interferon gamma (IFN), and tumor necrosis factor-alpha (TNF alpha) were determined in the mini-BAL fluid. Key features of the lung microbiome were measured: bacterial burden (16S rRNA gene copies/ml), community diversity (Shannon Diversity Index), and community composition. No statistically significant differences between the "uninflamed" and "reactive" ARDS subphenotypes were found in a selected set of alveolar inflammatory mediators and key features of the lung microbiome. LCA-derived subphenotypes and stratification based on cause of ARDS (direct vs. indirect) showed similar profiles, suggesting that current subphenotypes may not reflect the alveolar host response. It is important for future research to elucidate the pulmonary biology within each subphenotype properly, which is arguably a target for intervention.
U2 - 10.14814/phy2.14693
DO - 10.14814/phy2.14693
M3 - Article
C2 - 33547768
SN - 2051-817X
VL - 9
JO - Physiological Reports
JF - Physiological Reports
IS - 3
M1 - e14693
ER -